BridgeMD
Clinical trial to compare the efficacy and safety of Buckberg versus Del Nido cardioplegia in isolated myocardial revascularization surgery
EU CTIS ID: 2023-505855-32-01
What this study is testing
The main objective of the study is to study the efficacy and safety in terms of myocardial protection in patients undergoing isolated myocardial revascularization surgery with extracorporeal circulation of two cardioplegic solutions: Del Nido cardioplegia versus Buckberg cardioplegia. For this purpose, levels of myocardial injury markers (CK and Troponin T) and in-hospital mortality will be compared between both strategies.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients of legal age (>18 years) of both sexes.
- Patients undergoing isolated myocardial revascularization surgery with extracorporeal circulation.
- Patients providing the informed consent.
You likely can't join if
- Emergent surgery
- Acute coronary syndrome with or without ST elevation in the last 48 hours.
- Patient who rejects blood products
- Patients with concomitant medical conditions that determine the need to use one or another cardioplegic solution; such as advanced chronic kidney disease, diabetes with poor glycemic control or significant preoperative anemia that requires hemodilution to be reduced as much as possible.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.